Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
10h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
11h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
13h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
20h agoBuffalo Potash Files Annual Information Form and New Technical Report
21h agoIonik Announces 30-Day Extension of Senior Debt Facility
Pliant Therapeutics, Inc. logo

Pliant Therapeutics, Inc.

About

1.21USD-0.02 -1.63%
Closed • Updated at 00:25 GMT+00:00
Market Cap$74.92M
Volume212.1K
Beta1.34
RSI48.81
Health TechnologyBiotechnology

Pliant Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 21 2026
Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
May 11 2026
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 6 2026
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
Apr 30 2026
Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors
Apr 18 2026
Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting

Community Chat

Ask AI

Try asking
6ix6ixAIEvents